• Skip to main content
  • Skip to secondary menu
  • Skip to primary sidebar
  • Skip to footer
California Health Advocates

California Health Advocates

  • Contact
  • Home
  • About Us
    • Contact
    • Our Team
    • Mission
    • Education Services
    • About HICAP
    • Press
    • Testimonials
  • MEDICARE COUNSELING
  • Fact Sheets
  • Topics
    • The Basics
    • Prescription Drugs
    • Low-Income Help
    • Medigap
    • Medicare Advantage
    • Other Health Insurance
    • Appeals
    • Billing & Claims
    • Disabilities
    • Long-Term Care
    • Tribal Nations & Medicare
    • Health Care Reform
    • Advocacy & Policy
    • Glossary
  • Fraud & Abuse
  • Medicare Complaints
  • Blog
  • Donate

New Marketing Rules Fail to Cure Problems in the Medicare Marketplace

California Health Advocates > News > Prescription Drugs > New Marketing Rules Fail to Cure Problems in the Medicare Marketplace

Posted by Karen Joy Fletcher on January 7, 2009

We recently published an issue brief exploring how the new marketing rules for the sale of Medicare Part C and D plans have failed to cure the problems in Medicare’s marketplace.

Even though, Congress and the Centers for Medicare and Medicaid Services (CMS) have made progress in their recognition of and efforts to address marketing misconduct in the Medicare marketplace, many problems persist. This year Congress passed the Medicare Improvements for Patients and Providers Act of 2008 (MIPPA) and CMS has issued implementing regulations and clarifying guidance. Many of the statutory and regulatory changes do improve beneficiary protections, but they also have some significant loopholes and/or exceptions, and it is yet unclear how some of the rules will be implemented. Some of these new rules are codifications of existing rules (e.g. a prohibition on unsolicited door-to-door marketing) that, in the view of those assisting Medicare beneficiaries, have been widely flaunted. Although the new rules will help, this issue brief points out how and why marketing misconduct continues. It discusses some ongoing systemic barriers to adequate oversight of the Medicare marketplace, such as the federal preemption that still plagues the regulation of Medicare Advantage and Part D plans by hindering or even preventing action at the state level, and the sporadic oversight and enforcement actions at the federal level.

This brief also reviews some of the changes in marketing rules implemented in 2008 by identifying strengths, weaknesses, and room for improvement. The brief is organized as follows:

  • Part I provides a short overview of regulation changes to the Medicare marketplace in the last couple of years;
  • Part II explores unresolved systemic issues that prevent adequate oversight of marketing in the Medicare marketplace;
  • Part III analyzes selected new marketing rules, including their shortcomings;
  • Part IV provides recommendations to better protect consumers from marketing abuses;
  • Appendix 1: is an update on Medicare Advantage “Gap” Plans (following-up on an issue brief on the subject drafted by California Health Advocates in November 2007), along with a couple of examples of ongoing marketing of these products to agents; and
  • Appendices 2 and 3 are examples of marketing documents referenced in the text.

View the full issue brief (pdf).

Also, learn more about Medicare Advantage plans and Medicare Part D plans.

Filed Under: Medicare Advantage, Prescription Drugs

Previous Post: « CHA Comments on CMS’ Proposed Rules on New Compensation Limits for Agents Selling Medicare Part C & D Plans
Next Post: CMS Issues Star Quality Rating System for Nursing Home Compare »

About Karen Joy Fletcher

Our blogger Karen Joy Fletcher is CHA's Communications Director. With a Masters in Public Health from UC Berkeley, she is the online "public face" of the organization, provides technical expertise, writing and research on Medicare and other health care issues. She is responsible for digital content creation, management of CHA’s editorial calendar, and managing all aspects of CHA’s social media presence. She loves being a "communicator" and enjoys networking and collaborating with the passionate people and agencies in the health advocacy field. See her current articles.

Related Posts

  • Unhappy with your Medicare Advantage Plan? You Can Change Your Coverage Before 3/31
  • Congress Expresses Concerns on the New Medicare Plan Finder
  • While Medicare’s Open Enrollment is Over, Consequences for the Medicare Plan Finder’s Inaccuracies Are Not
  • Low Performing Health & Drug Plans Get Another Year

Primary Sidebar

Change Text Size

  • 100%  110%  120%  130%  

News & Blog Categories

  • Medicare Advantage
  • Low-Income help
  • Medicare & Disabilities
  • Medicare Basics
  • Prescription Drugs
  • Medicare & Other Health Insurance
  • Medicare Billings, Claims & Appeals
  • Health Care Disparities
  • Fraud & Abuse

—

  • COVID-19
  • Resources
  • Health Care Reform
  • Long-Term Care
  • CHA News

—

  • Advocacy & Policy
  • Letters and Comments to Policymakers
  • Legislative and Congressional Testimony
  • Policy Briefs

Send Us Comment

Do you have comments or concerns about your Medicare coverage? Issues regarding getting your needed prescriptions from your Part D plan, or a Medicare Advantage plan representative's marketing practices? Let us know at comments@cahealthadvocates.org.

We are dedicated to making Medicare's program work well for all beneficiaries. Your feedback from your own or your client's concerns and experiences with Medicare, will guide our Medicare advocacy efforts with key policy and decision-makers in both California and nationally with the Centers for Medicare and Medicaid Services (CMS) and Congress.

Archives

Donate Today

Footer

Sign up for our newsletter

Choose the news you'd like to receive

Important Links

  • About Us
  • Fact Sheets
  • Blog
  • Donate
  • Contact
  • Privacy Notice
  • Cookie Policy
  • Accessibility Statement

Follow Us

Copyright © 2023 · California Health Advocates · Web Design by TWK Web and Print Design · Log in